Unidad TPH La Fe

PEDRO IS ON FIRE! The level of insight he’s generating is unreal. What a team!!astctjournal.org/article/S2666-… @TheEBMT @GETH_info @IISLaFe

First results are in the multidisciplinary GVHD team at LA FE @IISLaFe @TheEBMT @GETH_info .astctjournal.org/article/S2666-…

Another one! What an incredible year it’s been! Huge congrats to Juan on the EBMT study collaboration on HSCT in ALL. Now for a well-deserved summer break!@ @IISLaFe @Mohty_EBMT @TheEBMT @GETH_info @HospitalLaFe nature.com/articles/s4140…

Another one accepted! The team's on an incredible streak — what a year we're having! Engraftment Syndrome after Post-Transplant Cyclophosphamide Allogeneic Hematopoietic Cell Transplantatio… pubmed.ncbi.nlm.nih.gov/40490079/ @TheEBMT @GETH_info @IISLaFe @HospitalLaFe

Another one! Big congrats to Aitana! Our team's scientific production is unstoppable! Sinusoidal Obstruction Syndrome after Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosp… pubmed.ncbi.nlm.nih.gov/40404101/ @GETH_info @TheEBMT @IISLaFe @HospitalLaFe

A new manuscript in collaboration with the EBMT. This time about aplastic anemia. What a productive year it's been for the Unit. Donor impact on allo-SCT outcomes with PTCy for SAA: a study of the SAAWP EBMT pubmed.ncbi.nlm.nih.gov/40425810/ @GETH_info @HospitalLaFe @TheEBMT @IISLaFe

Another manuscript! This from our colleague from Chile, who chose to stay with the team not just to learn, but to actively drive impactful research. CRS syndrome: implications for transplant outcomes in haplo and HLA-matched HSCT using PTCy @GETH_info" target="_blank" rel="nofollow noopener">pubmed.ncbi.nlm.nih.gov/40269279/@GETH… @TheEBMT

Congratulations to the team on the new manuscript! We continue to push forward—great work Pedro!! Infectious Enterocolitis in Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide pubmed.ncbi.nlm.nih.gov/40068801/ @GETH_info @GVAsanitat @IISLaFe @HospitalLaFe @TheEBMT

📊 Memoria TPH 2024 publicada ❤️ 101 pacientes alotrasplantados Un año más, seguimos como el centro nacional con mayor actividad en alo-TPH. Gracias a todos los que lo hacéis posible. Enhorabuena, equipo. @GVAsanitat @HospitalLaFe @GETH_info @TheEBMT @IISLaFe @ONT_esp @fcarreras

🏥La Fe formaliza la creación de un comité multidisciplinar para el abordaje de la enfermedad de #injerto contra receptor ‼️Es una complicación inmunológica, multiorgánica y potencialmente mortal 🔗organismes.san.gva.es/es/web/lafe/-/…

@MartaVM90 Relapse patterns after antiCD19 #CART cell therapy + role of allo #SCT, by @aitana_balag , project in collaboration with Dr Mussetti, from @HematICO_Hosp

@MartaVM90 T-ICAHT, a novel grading system for #CART cell therapy, presented by Jaime Sanz

This #EBMT25 our group is on fire!! Four oral communications (including Juan Montoro at the Presidential Symposium), two posters. Well done! 👏👏@HospitalLaFe @GETH_info #SCT

Congratulations to the team on the new manuscript! Despite the tremendous patient burden assistance, we keep pushing forward! Incidence, Risk Factors, and Outcomes of BK Hemorrhagic Cystitis in He... sciencedirect.com/science/articl…

A very nice manuscript published by our team. Congrats Juan!!Gastric Bleeding in Stem Cell Transplantation: A Focus on Gastric Vascular Ectasia Under Post-Transplant Cyclophosp… pubmed.ncbi.nlm.nih.gov/39424278/

Otro trabajo publicado por nuestro equipo: la historia de 45 años de alo-TPH en La Fe. Las curvas lo dicen todo. "Longitudinal outcome over 4 decades of allo-SCT: a single center experience @GETH_info @sehh_es @TheEBMT @HospitalLaFe nature.com/articles/s4140…

We are pleased to announce that, once again, our team has achieved the highest ALLO-HSCT activity in Spain! This accomplishment is a testament to the hard work, dedication, and commitment of our team @GETH_info @sehh_es @ONT_esp @GVAsanitat @IISLaFe @HospitalLaFe @TheEBMT

Our team never stops! Congratulations to Juan for the publication of his significant manuscript in Blood Advances @GETH_info @TheEBMT @sehh_es @IISLaFe @HospitalLaFe @GVAsanitat ashpublications.org/bloodadvances/…